XARELTO CAREPATH Trademark

Trademark Overview

On Friday, June 10, 2011, a trademark application was filed for XARELTO CAREPATH with the United States Patent and Trademark Office. The USPTO has given the XARELTO CAREPATH trademark a serial number of 85343299. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 28, 2020. This trademark is owned by Bayer Aktiengesellschaft. The XARELTO CAREPATH trademark is filed in the Paper & Printed Material Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Publications in the nature of brochures, pamphlets, hand-outs and leaflets related to patient support programs in the field of thrombosis

Providing medical information on thrombosis, providing medical information on pharmaceuticals for the treatment of thrombosis; medication therapy management, namely, providing information to patients by certified health care professionals in the field of administering medications
xarelto carepath

General Information

Serial Number85343299
Word MarkXARELTO CAREPATH
Filing DateFriday, June 10, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 28, 2020
Registration Number4373006
Registration DateTuesday, July 23, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2012

Trademark Statements

Goods and ServicesPublications in the nature of brochures, pamphlets, hand-outs and leaflets related to patient support programs in the field of thrombosis
Goods and ServicesProviding medical information on thrombosis, providing medical information on pharmaceuticals for the treatment of thrombosis; medication therapy management, namely, providing information to patients by certified health care professionals in the field of administering medications
Pseudo MarkXARELTO CARE PATH

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 28, 2020
Primary Code016
First Use Anywhere DateFriday, July 1, 2011
First Use In Commerce DateFriday, July 1, 2011
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 28, 2020
Primary Code044
First Use Anywhere DateFriday, July 1, 2011
First Use In Commerce DateFriday, July 1, 2011

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Friday, February 28, 2020CANCELLED SEC. 8 (6-YR)
Monday, July 23, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 23, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 17, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 14, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, June 7, 2013USE AMENDMENT FILED
Wednesday, June 12, 2013EXTENSION 2 GRANTED
Friday, June 7, 2013EXTENSION 2 FILED
Friday, June 7, 2013TEAS EXTENSION RECEIVED
Friday, June 7, 2013TEAS STATEMENT OF USE RECEIVED
Saturday, December 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 21, 2012EXTENSION 1 GRANTED
Wednesday, December 12, 2012EXTENSION 1 FILED
Friday, December 21, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 12, 2012TEAS EXTENSION RECEIVED
Monday, July 2, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 2, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 12, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 13, 2012ASSIGNED TO LIE
Tuesday, February 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2012EXAMINER'S AMENDMENT ENTERED
Tuesday, February 28, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 28, 2012EXAMINERS AMENDMENT E-MAILED
Tuesday, February 28, 2012EXAMINERS AMENDMENT -WRITTEN
Thursday, February 23, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 23, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 17, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 17, 2011NON-FINAL ACTION E-MAILED
Saturday, September 17, 2011NON-FINAL ACTION WRITTEN
Friday, September 16, 2011ASSIGNED TO EXAMINER
Thursday, June 16, 2011NOTICE OF PSEUDO MARK MAILED
Wednesday, June 15, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 14, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

carepath xarelto thrombosis providing information field medical namely patients management therapy medication